IndraLab

Statements


BRAF binds KRAS, mtnN, and mcrC. 2 / 2
| 2

sparser
"In conclusion, our data suggest that mutations in KRAS and BRAF are associated with inferior PFS and OS of mCRC patients compared with patients with non-mutated tumors."

sparser
"Mutations in KRAS and BRAF were associated with inferior PFS and OS of mCRC patients compared with patients with non-mutated tumors."